USF Health’s IDPodcasts

Episod

• 
  What To Do With a Positive Blood Culture 10.08.2026 58min

  Dr. Richard Oehler, Professor of Medicine at the Division of Infectious Diseases/USF Morsani College of Medicine, presents a review of bacteremia. Dr. Oehler begins by reviewing the epidemiology, personal and institutional costs of bacteremia. He then discusses blood culture collection and how false positive blood cultures occur. Next, Dr. Oehler reviews automated blood culture systems and multiplex PCR and MALDI-TOF technology. The speaker then contrasts gram positive and gram negative bacteremia in general and by organism. The management of a positive blood culture with regard to treatment and source control is discussed. Lastly, ways to reduce the incidence of bacteremia are shared.
• 
  Infections in Hematologic Malignancies and Stem Cell Transplantation 04.08.2026 1j 21min

  Dr. Olga Klinkova, Infectious Diseases Physician at the Moffitt Cancer Center and Research Institute, presents an introductory session on the management of the immunocompromised patient. Dr. Klinkova begins by explaining the major immune deficits in patients with hematologic malignancy and stem cell transplantation (SCT). She then outlines the likely pathogens that produce infections based on the timeline after cancer therapy or SCT. She further explains the major pulmonary syndromes seen in hematologic malignancies and transplant. Lastly, she discusses infections that can occur after CAR-T therapies as well as CMV infection post-transplant.
• 
  Microbiology 101 21.07.2026 58min

  Dr. Suzane Silbert, Director of Tampa General Hospital’s Microbiology laboratory, presents an introductory lecture on the modern infectious diseases laboratory. Topics covered include basic microorganism classification schemes, basic microscopy, E tests, culture techniques, mass spectroscopy, PCR assays, and other molecular technology. Syndromic multiplex panels are also mentioned. The lecture is suitable for medical trainees, medical residents, and infectious diseases fellows.
• 
  ID Board Review: Peds, Pregnancy, Parasites, Protozoa and Prophylaxis 02.07.2026 55min

  Dr. Shylah Moore-Pardo, associate program director of the ID fellowship program at the Morsani College of Medicine, conducts this interactive board review suitable for Medical Students, Residents, and Fellows. Five different categories of questions are covered.
• 
  Candida Infections Board Review 12.06.2026 53min

  Dr. Olga Klinkova, Infectious Diseases clinician at Moffitt Cancer Center and Research Institute, conducts a board review session on Candida Infections targeted towards the medical resident or Infectious Diseases Fellow. Topics discussed include a comparison and contrast of the different Candida species, information on Candida auris, Candidemia, and disseminated (hepatosplenic) candidiasis. Also discussed are novel antifungals used for azole-resistant candidiasis. Guidelines based reference sources are also mentioned.
• 
  Antimicrobial Side Effects: The Zebras, Not the Horses 08.06.2026 36min

  Dr. Yanina Pasikhova, Infectious Diseases Pharmacist at Moffitt Cancer Center and Research Institute, presents a talk on three lesser well known adverse drug effects involving antimicrobials. Dr. Pasikhova discusses the link between voriconazole and bone pain, the association between posaconazole and refractory hypertension and hypokalemia, and the neurological effects of of metronidazole therapy. Clinical pearls are provided for each interaction discussed.
• 
  Rickettsial Infections 22.05.2026 44min

  Dr. Medaris, Chief of Infectious Diseases at Bay Pines Medical Center in St. Petersburg, Florida, conducts a review of Rickettsial Infections. After starting with an overview of the genus Rickettsia, Dr. Medaris moves on to discuss Rocky Mountain Spotted Fever, R. Parkeri, Mediterranean Spotted Fever, and Rickettsial Pox. African Tick Bite Fever is next discussed, followed by Sylvatic and Murine Typhus. Lastly, Dr. Medaris discusses Coxiella infections. Though not strictly a Rickettsiosis, it shares similarities with the Rickettsial group. The lecture is suitable for board review or for gaining further knowledge regarding these unusual pathogens.
• 
  PrEPare for a PEP Talk 04.05.2026 40min

  Dr. Drew Wilson, ID Pharmacy Resident, discusses the new options for pre-exposure prophylaxis (PrEP) to prevent HIV infection. Options discussed include oral PrEP (Truvada, Descovy), cabotegravir, and a newer option, lenacapravir. A prescribing algorithm is also presented, and the topic of developing resistance is also covered. Lastly, Dr. Wilson touches upon other novel agents for PrEP, as well as DoxyPEP for the prevention of bacterial STIs.
• 
  IDMythbusters: Evaluating Historical and Current Practice Patterns 24.04.2026 45min

  Parker Kaleo, PharmD, Pgy2 ID Pharmacy Resident, presents a review of several recent controversies in infectious diseases. He addresses the optimal therapy for refractory MSSA bacteremia, the use of “cidal” versus “bacteriostatic” antimicrobials for severe infections, oral cephalosporins as step down therapy for severe infections, the penetration of cefazolin for CNS infections, and the use of isuvaconazole for Candida albicans infections. The presentation is given in a “confirmed,” “plausible,” or “busted ” format.
• 
  Diabetic Foot Infections Management for 2026 17.04.2026 1j 1min

  Dr. Richard L. Oehler, MD, Professor of Medicine at the USF Morsani College of Medicine, presents this update on Diabetic Foot Infections (DFIs) in 2026. Focusing on recent guidelines and scientific literature, Dr. Oeher discusses DFI epidemiology, pathophysiology, and Diabetic foot exam basics. He then goes on to review diabetic vascular disease and its role in the progression of diabetic foot complications. Dr. Oehler then reviews the workup of diabetic foot infections including imaging and physical examination findings. Lastly, the management of diabetic foot osteomyelitis is discussed including treatment strategies and prevention.
• 
  Travel Medicine, Puerto Rico Edition 06.04.2026 49min

  Dr. Cordero-Baez, MD, Infectious Diseases Fellow at the Morsani USF College of Medicine, presents a lighthearted (and Bad Bunny-inspired) look at travel medicine recommendations for Puerto Rico, a popular travel destination (and his home country) in the Caribbean. Dr. Cordero starts by taking a close look at Dengue, for which cases experienced a surge on the island as recently as in 2024. He then discusses Zika virus, including the viruses epidemiology, transmission vectors, clinical manifestations, and complications. Chikungunya virus is also briefly discussed. He closes by discussing ciguatera poisoning and several other transmissible syndromes.
• 
  Mechanisms of Gram Negative Resistance: Part II–Therapeutics 24.03.2026 7min

  Dr. Mel O’Neal, Infectious Diseases pharmacist at Tampa General Hospital, presents part 2 of her series on Gram Negative Resistance, focusing on therapeutics for treatment of these resistant pathogens. Dr. O’Neal begins by identifying the main resistance mechanisms, including membrane porins, efflux pumps, drug binding site mutations, and degrading enzymes (e.g., beta-lactamases.) She then systematically covers the major agents used for treating resistant gram negative rods, including the newer beta-lactamase inhibitors, cefiderocol, and third-generation tetracyclines. Cases are also presented to emphasize the topics covered.
• 
  Infections Caused by Nocardia and Actinomyces 20.02.2026 36min

  Dr. Richard Oehler, Professor of Medicine at the Division of Infectious Diseases and International Medicine, Morsani College of Medicine at USF, presents this updated overview of Nocardia and Actinomyces, two closely-related gram positive filamentous rods which have distinct differences. In his presentation, Dr. Oehler initially covers Nocardiosis, followed by Actinomycosis, and compares and contrasts both and how they produce human infection. Topics covered for both infections include their taxonomy, epidemiology, types of patients infected, infectious syndromes, potential complications, recommended therapies, and duration of treatment. At the end of the talk both Nocardiosis and Actinomycosis are directly compared to help summarize the important learning points presented.
• 
  HIV Curriculum Series: Resistance 10.02.2026 49min

  Dr. Vivian Vega, Infectious Diseases clinician with the USF Morsani College of Medicine, presents a focused look at how to interpret HIV resistance patterns in clinical practice. Among the topics discussed include what constitutes a drug mutation, the specifics of having a high resistance barrier, when to obtain a genotype, and when to add an integrate inhibitor genotype. Lastly, specific classic mutations to memorize are discussed.
• 
  HIV Pre-exposure Prophylaxis Strategies 03.02.2026 51min

  Dr. Lauren Rybolt, Assistant Professor of Medicine at the USF Morsani College of Medicine, presents a talk on how to to tailor strategies for Pre-exposure prophylaxis, or “PREP,” to the individual patient. Dr. Rybolt begins by discussing USPSTF recommendations. She then moves on to compare and contrast the currently available options for PREP therapy, including TDF/FTC versus TAF/FTC, Cabotegravir, and Lenacapavir. Dr. Rybolt then discusses laboratory monitoring while on the drugs and modifications of PREP therapy in a patient who also has chronic hepatitis B. She closes with her final points regarding the individualization of PREP treatment and the need to continuously assess the patient’s ongoing risk factors.
• 
  The Compromised Host: Immune Defect-based Approach to Infection 26.01.2026 44min

  Dr. Marilia Bernardes, Infectious Diseases Faculty at the Morsani College of Medicine in Tampa, FL, presents an overview of the immune system. Dr. Bernardes skillfully breaks down the immune system into 4 distinct pillars and then its individual biological components. She presents the “who,” “what” and “why” for neutrophils, B-cells, and T cells and covers cellular and humoral immune deficits. She also covers newer immunotherapies such as BTK inhibitors, CAR-T and bispecifics, as well as biologics and other small molecules. Some rapid-fire cases are also presented to integrate the listener’s understanding of the material presented.
• 
  Gram Negative Resistance 20.01.2026 51min

  Dr. Melissa O’Neal, ID Clinical Pharmacist at Tampa General Hospital, provides an overview of gram negative resistance in this fast-paced presentation. Dr. O’Neal begins by describing the general mechanisms of antimicrobial resistance, including cell-wall dependent mechanisms and chromosomal mechanisms. She covers the alteration of membrane porins, over expression of efflux pumps, mutations of drug binding sites, and the production of enzymes that degrade antimicrobials. Next, the speaker covers the beta-lactamases, enzymes that degrade beta-lactam antibiotics, including penicillins, cephalosporins, and carbapenems. The Ambler class classification system is also covered, which offers a helpful way to differentiate the beta-lactamases by type of antimicrobial affected. Amp C resistance is also reviewed, and examples are provided, Lastly, specific bacterial resistance mechanisms are reviewed by each gram negative organism in order to help with knowledge retention.
• 
  Candidiasis 22.12.2025 1j

  Dr. Olga Klinkova, Infectious Diseases Clinician at the Moffitt Cancer Center and Research Institute, presents a talk on Candida Infections. Dr. Klinkova begins by discussing the epidemiology of Candida. She then touches upon the importance of biofilms on the pathogenicity of Candida strains. Next, she breaks down the individual Candida species and highlights unique characteristics of each one. Following this, she presents several unique cases of human Candida infections and through the cases, highlights Candida auris, oropharyngeal candidiasis, esophageal disease, and candidemia. Lastly, she closes with information on hepatosplenic candidiasis.
• 
  Research Methodology: Beyond the Jargon 28.11.2025 44min

  Dr. Ambuj Kumar, Professor of Medicine with the USF Morsani College of Medicine, shares his perspectives on how to create and conduct a clinical research study. Among the topics discussed includes study design, the distinctions between randomized controlled trials, case-control studies, and retrospective cohort trials, and how to frame the proper clinical question for study development. The importance of having timely and specific communication, teamwork, and respecting deadlines is also emphasized.
• 
  HIV Dermatology 2025 20.11.2025 56min

  Dr. Patrick Danaher, Infectious Diseases Clinician at the USF Morsani College of Medicine, discusses the various dermatologic manifestations of HIV in this recorded session. Among the topics discussed includes genital herpes disease, Zoster, Mpox infections, MRSA skin lesions, and Kaposi sarcoma. The lecture is presented in a case-based interactive format and is updated for 2025